supp.fit

Docosahexaenoic Acid, Vitamin E and Fish Oil: study protocols

5 study groups took Docosahexaenoic Acid together with Vitamin E and Fish Oil. These are the doses the studies gave. They are not a recommendation.

Docosahexaenoic Acid: what the research found →

Dose per serving from research: Docosahexaenoic Acid

5 study groups in 5 studies say how much Docosahexaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 60% of 5 study groups.

Daily doseStudy groups
100 mg to 250 mg
1
250 mg to 500 mg
3
500 mg to 1 g
0
over 1 g
1

Dose per serving from research: Fish Oil

5 study groups in 5 studies say how much Fish Oil participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 60% of 5 study groups.

Daily doseStudy groups
1 g or less
1
1 g to 2.5 g
3
2.5 g to 5 g
0
5 g to 10 g
1

Commonly used together

5 of 5 study groups took Docosahexaenoic Acid, Vitamin E and Fish Oil with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Omega-3 Fatty Acids
4

5 study groups

Study
The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: a randomized clinical trial
2020 · fish oil group · Adults aged 30–54 years with low dietary EPA and DHA intake and no stated diagnosed condition
400 mg10 IU2 g18 weeks134
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · ω-3 PUFA group · People aged 13–25 with ultra-high risk for psychosis
480 mg7.6 mg2 g12 weeks40
Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial
2022 · active group · Cognitively healthy adults aged 65 years and older
430 mg15 mg1 g2 years30
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · fish oil (FO) · Healthy subjects; age and sex not specified
1.1 g205 mg9 g12 weeks—
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
200 mg400 IU1.05 g—10
Docosahexaenoic Acid, Vitamin E and Fish Oil: study protocols | supp.fit